awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52668159-07583101-3C1B-46FC-86A8-8667BBECFD7F
Q52668159-07583101-3C1B-46FC-86A8-8667BBECFD7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668159-07583101-3C1B-46FC-86A8-8667BBECFD7F
Newly developed anti-angiogenic therapy in non-small cell lung cancer.
P2860
Q52668159-07583101-3C1B-46FC-86A8-8667BBECFD7F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52668159-07583101-3C1B-46FC-86A8-8667BBECFD7F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c9fd30209b6d64102bcf7d47664b3015f35e6a2
P2860
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).